Immunotherapy News and reporting on cancer immunotherapy. Sep 21, 2022 Propath UK, Nucleai Partner on Spatial Proteomics Panel for Immuno-Oncology Sep 20, 2022 Gradalis' Autologous Immunotherapy Shows Promise in Certain Ovarian Cancer Patients Premium Sep 20, 2022 Verismo Therapeutics to Begin Phase I Trial of Autologous Cell Therapy SynKIR-110 Sep 16, 2022 BMS Combo Immunotherapy Opdualag Approved in Europe for Biomarker-Defined Melanoma Patients Sep 16, 2022 Biocytogen Pharmaceuticals, Guangzhou FineImmune Biotechnology Ink Cell Therapy Partnership Sep 15, 2022 BriaCell, Caris Life Sciences Partner to Bolster New Immunotherapy Development Sep 13, 2022 Nearly all dMMR Colon Cancer Patients Respond in Trial of Neoadjuvant Opdivo-Yervoy Premium Sep 11, 2022 TIL Therapy Bests Yervoy in Head-to-Head Melanoma Trial; Will It Reach Patients Without Pharma? Premium Sep 10, 2022 BMS Combo Drug Opdualag Effective in Neoadjuvant NSCLC, But Maybe No Better Than Opdivo Alone Premium Sep 7, 2022 Roche to Acquire Good Therapeutics for $250M Sep 6, 2022 Elephas Biosciences Raises $41.5M in Series B Funding Sep 1, 2022 Multiple Myeloma Researchers Chip Away at Why Some Patients Relapse Quickly After CAR T-Cell Therapy Premium Sep 1, 2022 Aston Sci. to Launch Phase II US Study of Experimental Vaccine in HER2-Low Breast Cancer Patients Aug 30, 2022 Jounce Therapeutics' Vopratelimab, Pimivalimab Combo Trial in NSCLC Fails to Meet Primary Endpoint Aug 26, 2022 Melanoma Docs Resurrect PD-L1 Debate as CHMP, FDA Diverge on Opdualag Label Premium Aug 24, 2022 Roche Gets Expanded CE Mark for Ventana PD-L1 Assay to ID NSCLC Patients for Tecentriq Aug 19, 2022 Verismo Therapeutics Files IND to Study Cell Therapy in Advanced Mesothelin-Expressing Solid Tumors Aug 18, 2022 Innovative Cellular Therapies Begins Trial of Autologous CAR T-Cell Therapy in Colorectal Cancer Aug 17, 2022 Tessa Therapeutics Starts Trial of CAR T-Cell Therapy, BMS's Opdivo in Classical Hodgkin Lymphoma Aug 15, 2022 Anixa Biosciences Doses First Ovarian Cancer Patient in Novel Autologous Cell Therapy Trial Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
